A detailed history of Moseley Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Moseley Investment Management Inc holds 6,115 shares of AMGN stock, worth $1.62 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
6,115
Previous 6,205 1.45%
Holding current value
$1.62 Million
Previous $1.94 Million 1.65%
% of portfolio
0.8%
Previous 0.91%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$309.38 - $337.38 $27,844 - $30,364
-90 Reduced 1.45%
6,115 $1.97 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $12,874 - $15,646
49 Added 0.8%
6,205 $1.94 Million
Q1 2024

Apr 04, 2024

BUY
$268.87 - $324.56 $62,915 - $75,947
234 Added 3.95%
6,156 $1.75 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $18,154 - $20,480
71 Added 1.21%
5,922 $1.71 Million
Q3 2023

Oct 16, 2023

BUY
$218.65 - $271.46 $8,746 - $10,858
40 Added 0.69%
5,851 $1.57 Million
Q2 2023

Jul 06, 2023

BUY
$214.27 - $253.37 $10,070 - $11,908
47 Added 0.82%
5,811 $1.29 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $7,225 - $8,806
32 Added 0.56%
5,764 $1.39 Million
Q4 2022

Jan 24, 2023

BUY
$229.03 - $291.01 $9,390 - $11,931
41 Added 0.72%
5,732 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $448 - $506
-2 Reduced 0.04%
5,691 $1.28 Million
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $187,797 - $208,986
-814 Reduced 12.51%
5,693 $1.39 Million
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $83,761 - $92,661
-382 Reduced 5.55%
6,507 $1.57 Million
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $253,969 - $290,645
1,277 Added 22.75%
6,889 $1.55 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $90,214 - $105,697
425 Added 8.19%
5,612 $1.2 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $57,927 - $64,266
248 Added 5.02%
5,187 $1.26 Million
Q1 2021

Apr 19, 2021

BUY
$221.91 - $258.6 $135,587 - $158,004
611 Added 14.12%
4,939 $1.23 Million
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $310,505 - $369,756
1,435 Added 49.6%
4,328 $995,000
Q3 2020

Nov 04, 2020

BUY
$234.65 - $260.95 $70,864 - $78,806
302 Added 11.66%
2,893 $735,000
Q2 2020

Jul 24, 2020

SELL
$197.81 - $242.74 $16,616 - $20,390
-84 Reduced 3.14%
2,591 $611,000
Q1 2020

Apr 20, 2020

BUY
$182.24 - $241.7 $49,022 - $65,017
269 Added 11.18%
2,675 $542,000
Q4 2019

Jan 15, 2020

BUY
$189.21 - $243.2 $13,055 - $16,780
69 Added 2.95%
2,406 $580,000
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $187,690 - $224,892
1,078 Added 85.62%
2,337 $452,000
Q2 2019

Jul 16, 2019

SELL
$166.7 - $195.41 $32,506 - $38,104
-195 Reduced 13.41%
1,259 $232,000
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $262,984 - $296,441
1,454 New
1,454 $276,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.